WO2014005494A1 - Method of preparing lactam compound - Google Patents

Method of preparing lactam compound Download PDF

Info

Publication number
WO2014005494A1
WO2014005494A1 PCT/CN2013/078258 CN2013078258W WO2014005494A1 WO 2014005494 A1 WO2014005494 A1 WO 2014005494A1 CN 2013078258 W CN2013078258 W CN 2013078258W WO 2014005494 A1 WO2014005494 A1 WO 2014005494A1
Authority
WO
WIPO (PCT)
Prior art keywords
combination
solvent
hydrate
halide
compound
Prior art date
Application number
PCT/CN2013/078258
Other languages
French (fr)
Inventor
Fang He
Yaobin ZHANG
Jingping KOU
Original Assignee
Sunshine Lake Pharma Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunshine Lake Pharma Co., Ltd. filed Critical Sunshine Lake Pharma Co., Ltd.
Priority to CN201380033724.XA priority Critical patent/CN104395286A/en
Publication of WO2014005494A1 publication Critical patent/WO2014005494A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/2672-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atom

Definitions

  • the present invention relates to a method of preparing pregabalin and the intermediate lactam compound.
  • Pregabalin has activities of analgesia, anticonvulsive and antianxiety, and can be used in preventing epilepsy.
  • the lactam compound, 4-isobutyl-2- pyrrolidinone (02) is a key intermediate in the synthesis of pregabalin.
  • a convenient process to get 4-isobutyl-2- pyrrolidinone (02) is very important for the preparation of pregabalin.
  • a method of preparing pregabalin comprises: transforming the nitro compound (01) to 4- isobutyl-2- pyrrolidinone (02), then hydro lyzing and resolving compound (02) to give pregabalin (03),
  • R is halo, OR 1 or NR 2 R 3 ; each of R 1 , R2 and R 3 is independently hydrogen, (C l -C6)alkyl, (C3-C6)cycloalkyl, aryl, methanesulfonyl, benzenesulfonyl and 4-methyl benzenesulfonyl, wherein the (C I - C6)alkyl, (C3 - C6)cycloalkyl or aryl is optionally unsubstituted or substituted with one or more substituents; wherein the (C I - C6)alkyl is but not limited to methyl, ethyl, i-propyl, t-butyl, etc; the (C3 - C6)cycloalkyl is but not limited to cyclopropyl, cyclohexyl; the aryl is but not limited to phenyl, tolyl; and hal
  • the method comprises transforming a nitro compound of formula (01) to 4-isobutyl-2-pyrrolidinone of formula (02) in the presence of a metal halide compound,
  • the nitro compound (01) can be prepared by a known method such as reported by Li Jing, et al. Chinese Journal of Medicinal Chemistry. 2007, volume 17, issue 1.
  • the method of preparing the lactam compound (02) from the nitro compound (01) comprises: in the presence of a metal halide compound, the nitro compound (01) is transformed to the lactam compound (02) through an intermediate (l - l),
  • the nitro compound (01) is transformed to the lactam compound (02) through an intermediate(I-II ), wherein the R of formula (I-II ) is as defined above,
  • the intermediate (I-I) or (I-II) can be separated or not. In some embodiments, the intermediate is not separated.
  • a reducing agent also is used in the transformation of the nitro compound (01) to the lactam compound (02).
  • a metal halide besides of a metal halide, a reducing agent and a metal catalyst can be used in the transformation of the nitro compound (01) to the lactam compound (02).
  • the nitro compound (01) is transformed to the lactam compound (02) by using a reducing agent in the presence of a metal halide; or the nitro compound (01) is reacted with a metal catalyst and a reducing agent, then transformed to the lactam compound (02) by using a reducing agent in the presence of a metal halide.
  • the metal halide is nickel halide, copper halide, tin halide, cobalt halide, or palladium halide, or their hydrate, or a combination thereof. In other embodiments, the metal halide is nickel halide, tin halide, or their hydrate, or a combination thereof.
  • the nickel halide is nickel chloride (NiCl 2 ), nickel chloride dihydrate ( ⁇ 2 ⁇ 2 ⁇ 2 0), nickel chloride hexahydrate (NiCl 2 -6H 2 0), nickel bromide (NiBr 2 ), nickel bromide trihdyrate (NiBr 2 -3H 2 0), or a combination thereof;
  • the copper halide is cuprous iodide (Cul), cupros bromide (CuBr) or a
  • the tin halide is stannous chloride dihydrate (SnCl 2 "2H 2 0), stannous chloride (SnCl 2 ), or a combination thereof;
  • the cobalt halide is cobalt chloride (CoCl 2 ) or its hydrate; and the palladium halide palladium chloride (PdCl 2 ).
  • the reducing agent is formic acid or its salt, a metal borohydride reagent, a metal hydride reagent, or a combination thereof.
  • the reducing agent is ammonium formate, sodium formate, formic acid, ammonium acetate, potassium borohydride, sodium borohydride, lithium aluminum hydride, sodium hydride, diisobutyl aluminium hydride, dimethylaminoborane, or a combination thereof.
  • the reducing agent is ammonium formate, potassium borohydride, sodium borohydride, or a combination thereof.
  • the reducing agent is potassium borohydride, sodium borohydride, or a combination thereof.
  • the metal catalyst is palladium-carbon (Pd/C), palladium hydroxide (Pd(OH) 2 ), platinum (Pt), platinum-carbon (Pt/C), nickel (Ni) catalyst, or a combination thereof.
  • the metal catalyst is palladium-carbon catalyst (Pd/C).
  • the metal catalyst is nickel catalyst (Ni).
  • the molar ratio of the nitro compound (01) to the metal halide is from 1 :0.1 to 1 :2.0. In some embodiments, the ratio is from 1 :0.3 to 1 : 1.0. In some embodiments, the ratio is froml :0.3 to 1 :0.8.
  • the molar ratio of the nitro compound (01) to the reducing agent is froml :0.5 to 1 :6. In some embodiments, the ratio is from 1 : 1.0 to 1 :6. In some embodiments, the ratio is from 1 : 1.1 to 1 :4.5. In some embodiments, the ratio is from 1 : 1.3 to 1 :4.5. In other embodiments, the ratio is froml : 1.3 to 1 : 1.4.
  • the weight ratio of the nitro compound (01) to the metal catalyst is from 1 :0.01 to 1 :0.2. In some embodiments, the ratio is from 1 :0.01 to 1 :0.1. In other embodiments, the ratio is froml :0.01 to 1 :0.05.
  • the pH value of the reaction mixture is controlled to eliminate the excess reactant to be lower than 6, or lower than 5, or lower than 4.5, or lower than 4.
  • the pH is controlled at 2-3 with aqueous hydrochloric acid solution.
  • the pH is 1 -2.
  • the reaction solvent is an alcohol solvent, a nitrile solvent, a ketone solvent, an ether solvent, an ester solvent, or a combination thereof.
  • the alcohol solvent is methanol, ethanol, i-propanol or a combination thereof; the nitrile solvent is acetonitrile; the ketone solvent is ketone; the ether solvent is tetrahydrofuran, 2-methyl tetrahydrofuran, methyl tert-butyl ether or a combination thereof; and the ester solvent is trimethyl orthoformate, triethyl orthoformate or a combination thereof.
  • the reaction solvent is methanol, ethanol, trimethyl orthoformate or a combination thereof.
  • the reaction temperature is from -40 °C to 65 °C. In some embodiments, the reaction temperature is from 0 °C to 45 °C.
  • the reaction time is from 0.5 hour to 20 hours.
  • the method that the nitro compound (01) is transformed to the lactam compound (02) comprises: reacting the nitro compound (01) with sodium borohydride in a solvent in the presence of NiCl 2 to give the lactam compound (02).
  • the nitro compound (01) is reacted with ammonium formate, potassium borohydride, sodium borohydride or a combination in the presence of Pd/C, then reduced by potassium borohydride or sodium boro hydride in the presence of NiCl 2 or SnCl 2 to get the lactam compound (02).
  • each number may differ by 1 %, 2%, 5%, 7%, 8%, 10%, 15% or 20%. Therefore, whenever a number having a value N is disclosed, any number having the value N+/-l %, N+/-2%, N+/-3%, N+/-5%, N+/-7%, N+/-8%, N+/-10%, N+/-15% or N+/-20% is specifically disclosed, wherein "+/-" refers to plus or minus. Whenever a numerical range with a lower limit, AL, and an upper limit, AU, is disclosed, any number falling within the range is specifically disclosed.
  • A AL+k*(AU-AL), wherein k is a variable ranging from 1% to 100% with a 1 % increment, i.e., k is 1 %, 2%, 3%, 4%, 5%,..., 50%, 51%, 52%,..., 95%, 96%, 97%, 98%, 99%, or 100%.
  • k is a variable ranging from 1% to 100% with a 1 % increment, i.e., k is 1 %, 2%, 3%, 4%, 5%,..., 50%, 51%, 52%,..., 95%, 96%, 97%, 98%, 99%, or 100%.
  • any numerical range defined by two R numbers as defined above is also specifically disclosed.
  • R is ethoxy. If R is other group, please reference the following examples to obtain the lactam compound (02).
  • Example 2 A solution of 50.00 g nitro compound (01) in methanol (600 mL) was cooled to -15°C. Then potassium borohydride (22.05g) and NiCl 2 6H 2 0 (10.93 g) were added.
  • ammonium formate (6.5 Og) and 10%Pd/C (0.15 g).
  • the solution was stirred at room temperature for 6.5 hours and cooled to 0°C.
  • sodium borohydride (1.09 g) and NiCl 2 ' 6H 2 0 (3.01 g) were added.
  • the mixture was heated to 45°C and stirred for 12 hours.
  • the mixture was cooled to 0°C-5°C and an aqueous solution of hydrochloride was added to adjust the pH of the solution to 1 -2.
  • the reaction mixture was concentrated until no obvious methanol was detected. Then it was extracted with ethyl acetate.
  • ammonium formate (6.50 g) and 5%Pd/C (0.25 g).
  • the solution was stirred at room temperature for 6.5 hours and cooled to 0°o.
  • sodium borohydride (1.84 g) and SnCl 2 ' 2H 2 0 (4.93 g) were added.
  • the mixture was heated to 45°C and stirred for 12 hours.
  • the mixture was cooled to 0°C-5°C and an aqueous solution of hydrochloride was added to adjust the pH of the solution to 1 -2.
  • the reaction mixture was concentrated until no obvious methanol was detected. Then it was extracted with ethyl acetate.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Provided is a method of preparing pregabalin and its important intermediate lactam compound. This method does not use hydrogen or high pressure equipment. By a convenient process, high purity of product can be obtained from selecting the proper catalyst and reducing agent with normal equipments. This method is convenient, safe and is of high yield, which is suitable for industry manufacture.

Description

A METHOD OF PREPARING A LACTAM COMPOUND
FIELD OF THE INVENTION
[001] The present invention relates to a method of preparing pregabalin and the intermediate lactam compound.
BACKGROUD OF THE INVENTION
[002] Pregabalin has activities of analgesia, anticonvulsive and antianxiety, and can be used in preventing epilepsy.
[003] The lactam compound, 4-isobutyl-2- pyrrolidinone (02) is a key intermediate in the synthesis of pregabalin. A convenient process to get 4-isobutyl-2- pyrrolidinone (02) is very important for the preparation of pregabalin.
Figure imgf000002_0001
(02)
[004] There are many methods for the preparation of 4- isobutyl-2- pyrrolidinone in prior art. For example, the patent application CN20091026661.8 or WO2006110783 discloses a related method of preparation of 4- isobutyl-2- pyrrolidinone. But these methods relate to using hydrogen (¾) and/or high pressure equipments or using other reactants to go through many steps to obtain the product with long reaction time, tedious processes and/or existing dangerous factors. Therefore, a safe method with lower requirements of equipment, convenient process and higher yield is required for industry manufacture.
SUMMARY OF THE INVENTION
[005] Provided herein is a method of preparing pregabalin, comprises: transforming the nitro compound (01) to 4- isobutyl-2- pyrrolidinone (02), then hydro lyzing and resolving compound (02) to give pregabalin (03),
Figure imgf000002_0002
(01 ) (02) (03) [006] wherein R is halo, OR 1 or NR 2 R 3 ; each of R 1 , R2 and R 3 is independently hydrogen, (C l -C6)alkyl, (C3-C6)cycloalkyl, aryl, methanesulfonyl, benzenesulfonyl and 4-methyl benzenesulfonyl, wherein the (C I - C6)alkyl, (C3 - C6)cycloalkyl or aryl is optionally unsubstituted or substituted with one or more substituents; wherein the (C I - C6)alkyl is but not limited to methyl, ethyl, i-propyl, t-butyl, etc; the (C3 - C6)cycloalkyl is but not limited to cyclopropyl, cyclohexyl; the aryl is but not limited to phenyl, tolyl; and halo is fluo, chloro, bromo or iodo; wherein each of the substituents is but not limited to one or more of halo, trifluoromethyl, nitro, cyano, thio, or alkylthio.
[007] Provided herein is a method of preparing a lactam compound (02), which doesn't use hydrogen (¾) and/or high pressure equipments and just uses convenient steps to get the lactam compound (02). The method comprises transforming a nitro compound of formula (01) to 4-isobutyl-2-pyrrolidinone of formula (02) in the presence of a metal halide compound,
Figure imgf000003_0001
(01 ) (02)
wherein R is as defined above.
[008] The nitro compound (01) can be prepared by a known method such as reported by Li Jing, et al. Chinese Journal of Medicinal Chemistry. 2007, volume 17, issue 1.
[009] In some embodiments, the method of preparing the lactam compound (02) from the nitro compound (01) comprises: in the presence of a metal halide compound, the nitro compound (01) is transformed to the lactam compound (02) through an intermediate (l - l),
Figure imgf000003_0002
(01 ) (l-l) (02) or in some embodiments, the nitro compound (01) is transformed to the lactam compound (02) through an intermediate(I-II ), wherein the R of formula (I-II ) is as defined above,
Figure imgf000003_0003
(01 ) (|_N) (02)
[0010] In the process of transforming of the nitro compound (01) into the lactam compound (02), the intermediate (I-I) or (I-II) can be separated or not. In some embodiments, the intermediate is not separated.
[0011] In some embodiments, besides of a metal halide compound, a reducing agent also is used in the transformation of the nitro compound (01) to the lactam compound (02).
[0012] In some embodiments, besides of a metal halide, a reducing agent and a metal catalyst can be used in the transformation of the nitro compound (01) to the lactam compound (02).
[0013] In some embodiments, the nitro compound (01) is transformed to the lactam compound (02) by using a reducing agent in the presence of a metal halide; or the nitro compound (01) is reacted with a metal catalyst and a reducing agent, then transformed to the lactam compound (02) by using a reducing agent in the presence of a metal halide.
[0014] In some embodiments, the metal halide is nickel halide, copper halide, tin halide, cobalt halide, or palladium halide, or their hydrate, or a combination thereof. In other embodiments, the metal halide is nickel halide, tin halide, or their hydrate, or a combination thereof. In some embodiments, the nickel halide is nickel chloride (NiCl2), nickel chloride dihydrate (ΝίΟ2·2Η20), nickel chloride hexahydrate (NiCl2 -6H20), nickel bromide (NiBr2), nickel bromide trihdyrate (NiBr2-3H20), or a combination thereof; the copper halide is cuprous iodide (Cul), cupros bromide (CuBr) or a
combination thereof; the tin halide is stannous chloride dihydrate (SnCl2"2H20), stannous chloride (SnCl2), or a combination thereof; the cobalt halide is cobalt chloride (CoCl2) or its hydrate; and the palladium halide palladium chloride (PdCl2).
[0015] In some embodiments, the reducing agent is formic acid or its salt, a metal borohydride reagent, a metal hydride reagent, or a combination thereof. In some embodiments, the reducing agent is ammonium formate, sodium formate, formic acid, ammonium acetate, potassium borohydride, sodium borohydride, lithium aluminum hydride, sodium hydride, diisobutyl aluminium hydride, dimethylaminoborane, or a combination thereof. In some embodiments, the reducing agent is ammonium formate, potassium borohydride, sodium borohydride, or a combination thereof. In some embodiments, the reducing agent is potassium borohydride, sodium borohydride, or a combination thereof.
[0016] In some embodiments, the metal catalyst is palladium-carbon (Pd/C), palladium hydroxide (Pd(OH)2), platinum (Pt), platinum-carbon (Pt/C), nickel (Ni) catalyst, or a combination thereof. In other embodiments, the metal catalyst is palladium-carbon catalyst (Pd/C). In some embodiments, the metal catalyst is nickel catalyst (Ni).
[0017] The molar ratio of the nitro compound (01) to the metal halide is from 1 :0.1 to 1 :2.0. In some embodiments, the ratio is from 1 :0.3 to 1 : 1.0. In some embodiments, the ratio is froml :0.3 to 1 :0.8.
[0018] The molar ratio of the nitro compound (01) to the reducing agent is froml :0.5 to 1 :6. In some embodiments, the ratio is from 1 : 1.0 to 1 :6. In some embodiments, the ratio is from 1 : 1.1 to 1 :4.5. In some embodiments, the ratio is from 1 : 1.3 to 1 :4.5. In other embodiments, the ratio is froml : 1.3 to 1 : 1.4.
[0019] The weight ratio of the nitro compound (01) to the metal catalyst is from 1 :0.01 to 1 :0.2. In some embodiments, the ratio is from 1 :0.01 to 1 :0.1. In other embodiments, the ratio is froml :0.01 to 1 :0.05.
[0020] In some embodiments, after complete reaction, the pH value of the reaction mixture is controlled to eliminate the excess reactant to be lower than 6, or lower than 5, or lower than 4.5, or lower than 4. In some embodiments, the pH is controlled at 2-3 with aqueous hydrochloric acid solution. In some embodiments, the pH is 1 -2.
[0021] In the process of transforming of the nitro compound (01) to the lactam compound (02), the reaction solvent is an alcohol solvent, a nitrile solvent, a ketone solvent, an ether solvent, an ester solvent, or a combination thereof. The alcohol solvent is methanol, ethanol, i-propanol or a combination thereof; the nitrile solvent is acetonitrile; the ketone solvent is ketone; the ether solvent is tetrahydrofuran, 2-methyl tetrahydrofuran, methyl tert-butyl ether or a combination thereof; and the ester solvent is trimethyl orthoformate, triethyl orthoformate or a combination thereof. In some embodiments, the reaction solvent is methanol, ethanol, trimethyl orthoformate or a combination thereof.
[0022] In the process of transforming of the nitro compound (01) to the lactam compound (02), the reaction temperature is from -40 °C to 65 °C. In some embodiments, the reaction temperature is from 0 °C to 45 °C. The reaction time is from 0.5 hour to 20 hours.
[0023] In some embodiments, the method that the nitro compound (01) is transformed to the lactam compound (02) comprises: reacting the nitro compound (01) with sodium borohydride in a solvent in the presence of NiCl2 to give the lactam compound (02).
[0024] In some embodiments, the nitro compound (01) is reacted with ammonium formate, potassium borohydride, sodium borohydride or a combination in the presence of Pd/C, then reduced by potassium borohydride or sodium boro hydride in the presence of NiCl2 or SnCl2 to get the lactam compound (02).
[0025] In the present invention, all numbers disclosed herein are approximate values, regardless whether the word "about" or "approximate" is used in connection
therewith. The value of each number may differ by 1 %, 2%, 5%, 7%, 8%, 10%, 15% or 20%. Therefore, whenever a number having a value N is disclosed, any number having the value N+/-l %, N+/-2%, N+/-3%, N+/-5%, N+/-7%, N+/-8%, N+/-10%, N+/-15% or N+/-20% is specifically disclosed, wherein "+/-" refers to plus or minus. Whenever a numerical range with a lower limit, AL, and an upper limit, AU, is disclosed, any number falling within the range is specifically disclosed. In particular, the following numbers within the range are specifically disclosed: A=AL+k*(AU-AL), wherein k is a variable ranging from 1% to 100% with a 1 % increment, i.e., k is 1 %, 2%, 3%, 4%, 5%,..., 50%, 51%, 52%,..., 95%, 96%, 97%, 98%, 99%, or 100%. Moreover, any numerical range defined by two R numbers as defined above is also specifically disclosed.
Examples
[0026] For further understanding of the present invention, disclosed herein is detailed description of the present invention with the examples.
[0027] In the following examples, R is ethoxy. If R is other group, please reference the following examples to obtain the lactam compound (02).
Example 1
[0028] To a solution of methanol (600 mL) were added 50.00 g nitro compound (01) and NiCl2 6H20 (18.04g). The solution was cooled to 0 aC - 5 °C, and sodium borohydride (18.2 g) was added. After addition, it was heated to 40 °C - 45 °C and stirred for 12 hours. Then the mixture was cooled to room temperature and an aqueous solution of
hydrochloride was added to adjust the pH of the solution to 2-3. The reaction mixture was concentrated until no obvious methanol was detected by gas chromatography (GC). The concentrate was extracted with ethyl acetate and the organic phase was washed with water, dried and concentrated to give the lactam compound (02), light yellow oil (31.20 g, yield 96.0%, purity 99.10%). Mass spectrum: m/z=142 [M+l ], m/z=283 [2M+1]; NMR spectrum: (CDC13, 400 MHz) 0.91 (m, 6H), 1.33(m,2H), 1.61 (m, lH), 1.99(m, lH),
2.17(m, lH), 2.44(m, lH), 3.01(m, lH), 3.50(m, lH), 6.71 (br, 1H).
Example 2 [0029] A solution of 50.00 g nitro compound (01) in methanol (600 mL) was cooled to -15°C. Then potassium borohydride (22.05g) and NiCl2 6H20 (10.93 g) were added.
After addition, the solution was heated to 45 °C and stirred for 12 hours. Then the mixture was cooled to 0°C-5°C and an aqueous solution of hydrochloride was added to adjust the pH of the solution to 2-3. The reaction mixture was concentrated and extracted with ethyl acetate. The organic phase was washed with water, dried and concentrated to give the lactam compound (02), light yellow oil (32.00 g, yield 98.5%, purity 96.50%; Mass spectrum: m/z=142 [M+l], m/z=283 [2M+1]).
Example 3
[0030] To a solution of methanol (500 mL) were added 50.00 g nitro compound (01) and NiBr2 '3H20 (31.35 g). The solution was cooled to -5°C, and sodium hydride (27.50 g) was added. After addition, it was heated to 40*C - 45*0 and stirred for 10 hours. Then the mixture was cooled to 0°C-5°C and an aqueous solution of hydrochloride was added to adjust the pH of the solution to 2-3. The reaction mixture was concentrated and extracted with ethyl acetate. The organic phase was washed with water, dried and concentrated to give the lactam compound (02), light yellow oil (31.1 Og, yield 95.7%, purity 99.11 %; Mass spectrum: m/z=142 [M+l ], m/z=283 [2M+1]).
Example 4
[0031] To a solution of methanol (900 mL) were added 50.00 g nitro compound (01) and NiCl2 '6H20 (24.65g). The solution was cooled to 0°C - 5*C, and sodium borohydride (18.20 g) was added. After addition, it was heated to 40°C - 45°C and stirred for 10 hours. Then the mixture was cooled to 5°C-25°C and an aqueous solution of hydrochloride was added to adjust the pH of the solution to 2-3. The reaction mixture was concentrated and extracted with ethyl acetate. The organic phase was washed with water, dried and concentrated to give the lactam compound (02), light yellow oil (31.22 g, yield 96.0%, purity 99.11 %; Mass spectrum: m/z=142 [M+l ], m/z=283 [2M+1]).
Example 5
[0032] To a solution of methanol (600 mL) were added 50.00 g nitro compound (01) and SnCl2 '2H20 (5.20 g). The solution was cooled to 0° C- 5°C, and sodium borohydride (18.20 g) was added. After addition, it was heated to 40 °C - 45°C and stirred for 10 hours. Then the mixture was cooled to 5°C- 15°C and an aqueous solution of
hydrochloride was added to adjust the pH of the solution to 2- 3. The reaction mixture was concentrated and extracted with ethyl acetate. The organic phase was washed with saturated NaCl solution, dried and concentrated to give the lactam compound (02), light yellow oil (31.30 g, yield 96.4%, purity 99.10%; Mass spectrum: m/z=142 [M+l ], m/z=283 [2M+1]).
Example 6
[0033] To a solution of ethanol (50 mL) were added 5 g nitro compound (01), ammonium formate (6.50 g) and 5%> Pd/C (0.25 g). The solution was stirred at room temperature for 6.5 hours and filtered. The filtrate was concentrated and exacted with ethyl acetate. The organic phase was washed with water, dried and concentrated to give yellow oil (3.30 g). The oil was dissolved in methanol (40 mL) and cooled to -10°C. Then potassium borohydride (2.51 g) and NiCl2 6H20 (1.37 g) were added. The mixture was heated to 45°C and stirred for 12 hours. Then the mixture was cooled to -5°C-0°C and an aqueous solution of hydrochloride was added to adjust the pH of the solution to 1 -2. The reaction mixture was concentrated until no obvious methanol was detected by GC. Then it was extracted with ethyl acetate. The organic phase was washed with water, dried and concentrated to give the lactam compound (02), light yellow oil (2.71 g, yield 82.6%>, purity 99.12%; Mass spectrum: m/z=142 [M+l ], m/z=283 [2M+1]).
Example 7
[0034] To a solution of methanol (60 mL) were added 5 g nitro compound (01),
ammonium formate (6.5 Og) and 10%Pd/C (0.15 g). The solution was stirred at room temperature for 6.5 hours and cooled to 0°C. Then sodium borohydride (1.09 g) and NiCl2 '6H20 (3.01 g) were added. The mixture was heated to 45°C and stirred for 12 hours. Then the mixture was cooled to 0°C-5°C and an aqueous solution of hydrochloride was added to adjust the pH of the solution to 1 -2. The reaction mixture was concentrated until no obvious methanol was detected. Then it was extracted with ethyl acetate. The organic phase was washed with water, dried and concentrated to give the lactam compound (02), light yellow oil (3.05 g, yield 94%, purity 99.12%; Mass spectrum: m/z=142 [M+l], m/z=283 [2M+1]).
Example 8
[0035] To a solution of methanol (60 mL)were added 5 g nitro compound (01),
ammonium formate (6.50 g) and 5%Pd/C (0.25 g). The solution was stirred at room temperature for 6.5 hours and cooled to 0°o. Then sodium borohydride (1.84 g) and SnCl2 '2H20 (4.93 g) were added. The mixture was heated to 45°C and stirred for 12 hours. Then the mixture was cooled to 0°C-5°C and an aqueous solution of hydrochloride was added to adjust the pH of the solution to 1 -2. The reaction mixture was concentrated until no obvious methanol was detected. Then it was extracted with ethyl acetate. The organic phase was washed with saturated NaCl solution, dried and concentrated to give the lactam compound (02), light yellow oil (3.04 g, yield 93.6%, purity 99.20%; Mass spectrum: m/z=142 [M+l], m/z=283 [2M+1]).
[0036] All above embodiments are just to help understanding the method of the present invention ant its core ideology. A skilled artisan in the field can conduct some
improvements and modifications without departing from the premise of principle of the present invention, which are also deemed to be within the scope of the present invention.

Claims

What is claimed is:
1. A method for preparing 4-isobutyl-2-pyrrolidinone comprising: preparing
4-isobutyl-2-pyrrolidinone of formula (02) with a nitro compound of formula (01)
presence of a metal halide,
Figure imgf000010_0001
(01 ) (02) wherein Ris halo, OR 1 or NR 2 R 3 ; each of R 1 , R2 and R 3 is independently hydrogen,
(Cl-C6)alkyl, (C3-C6)cycloalkyl, aryl, methanesulfonyl, benzenesulfonyl or 4-methyl benzenesulfonyl, wherein the (Cl-C6)alkyl, (C3-C6)cycloalkyl or aryl is optionally unsubstituted or substituted with one or more substituents, wherein each of the substituents is one or more of halo, trifluoromethyl, nitro, cyano, thio, alkylthio.
2. The method of claim 1, wherein the metal halide is nickel halide or its hydrate, copper halide or its hydrate, tin halide or its hydrate, cobalt halide or its hydrate, palladium halide or its hydrate, or a combination thereof; or wherein the metal halide is NiC12 or its hydrate, SnC12 or its hydrate, or a combination thereof.
3. The method of claim 1 or 2, wherein the reaction proceeds in the presence of a reducing agent.
4. The method of claim 3, wherein the reaction proceeds in the presence of a metal catalyst.
5. The method of claim 3 or 4, wherein the reducing agent is formic acid or its salt, a metal borohydride reagent, a metal hydride reagent or a combination thereof; or wherein the reducing agent is ammonium formate, sodium formate, formic acid, ammonium acetate, potassium borohydride, sodium borohydride, lithium aluminum hydride, sodium hydride, diisobutyl aluminium hydride, dimethylaminoborane or a combination thereof.
6. The method of claim 4, wherein the metal catalyst is Pd/C, Pd(OH)2, Pt, Pt/C, Ni or a combination thereof; or wherein the metal catalyst is Pd/C, Ni or a combination thereof.
7. The method of any one of claims 1-6, wherein in the transformation process of nitro compound (01) to the lactam compound (02), the reaction solvent is an alcohol solvent, a nitrile solvent, a ketone solvent, an ether solvent, an ester solvent, or a combination thereof; wherein the alcohol solvent is methanol, ethanol, i-propanol or a combination thereof; the nitrile solvent is acetonitrile; the ketone solvent is ketone; the ether solvent is tetrahydrofuran, 2-methyl tetrahydrofuran, methyl tert-butyl ether or a combination thereof; the ester solvent is trimethyl orthoformate, triethyl orthoformate or a combination thereof.
8. The method of claim 7, wherein the reaction solvent is methanol, ethanol or a combination thereof.
9. The method of any one of claims 2-3, wherein the nitro compound (01) is reacted with sodium borohydride or potassium borohrdride in a solvent to prepare the lactam compound (02) in the presence of NiC12, SnC12, or a hydrate thereof.
10. The method of any one of claims 2-3, wherein the nitro compound (01) is reacted with sodium borohydride or potassium borohrdride in methanol or ethanol to prepare the lactam compound (02) in the presence of NiC12, SnC12, or a hydrate thereof.
11. The method of any one of claims 4-8, wherein the nitro compound (01) is reacted with ammonium formate, potassium borohydride, sodium borohydride or a
combination in the presence of Pd/C, then it is reacted with potassium borohydride or sodium borohydride in the presence of NiC12, SnC12, or a hydrate thereof to prepare the lactam compound (02).
PCT/CN2013/078258 2012-07-02 2013-06-28 Method of preparing lactam compound WO2014005494A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201380033724.XA CN104395286A (en) 2012-07-02 2013-06-28 Method of preparing lactam compound

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201210222603 2012-07-02
CN201210222603.7 2012-07-02
CN201310117058.X 2013-04-04
CN201310117058 2013-04-04

Publications (1)

Publication Number Publication Date
WO2014005494A1 true WO2014005494A1 (en) 2014-01-09

Family

ID=49881328

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2013/078258 WO2014005494A1 (en) 2012-07-02 2013-06-28 Method of preparing lactam compound

Country Status (2)

Country Link
CN (1) CN104395286A (en)
WO (1) WO2014005494A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107641093A (en) * 2016-07-20 2018-01-30 江西科维协同创新药物有限公司 The method that one kind prepares the pyrrolidones of 4 (S) isobutyl group 2
CN115475162B (en) * 2022-10-18 2023-06-02 浙江震元制药有限公司 Application of 4-isobutyl-2-pyrrolidone in preparing analgesic drug and analgesic drug

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1642899A (en) * 2002-01-25 2005-07-20 格吕伦塔尔有限公司 Methods for producing substituted acrylic acid esters and use of the latter for producing substituted dollar G(G)-amino acids
WO2006110783A2 (en) * 2005-04-11 2006-10-19 Teva Pharmaceutical Industries Ltd. Process for making (s)-pregabalin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1642899A (en) * 2002-01-25 2005-07-20 格吕伦塔尔有限公司 Methods for producing substituted acrylic acid esters and use of the latter for producing substituted dollar G(G)-amino acids
WO2006110783A2 (en) * 2005-04-11 2006-10-19 Teva Pharmaceutical Industries Ltd. Process for making (s)-pregabalin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
COREY E. J. ET AL.: "Enantioselective Michael Addition ofNitromethane to a, B-Enones Catalyzed by Chiral Quaternary Ammonium Salts. A Simple Synthesis of (R)-Baclofen.", ORGANIC LETTERS., vol. 2, no. 26, 23 November 2000 (2000-11-23), pages 42574259 *

Also Published As

Publication number Publication date
CN104395286A (en) 2015-03-04

Similar Documents

Publication Publication Date Title
JP5107267B2 (en) Process for producing substituted biphenyls
US20110003999A1 (en) Process for Preparing Substituted Biphenylanilides
EP2619183B1 (en) Process for preparing substituted n-phenylhydroxylamines
MX2007009457A (en) Method for producing substituted biphenyls.
US9868694B2 (en) Process for preparing chlorinated biphenylanilides and biphenylanilines
US20110301356A1 (en) Method for Producing 2-aminobiphenylene
EP2473485A1 (en) Process for preparing 1-phenylpyrazoles
WO2014005494A1 (en) Method of preparing lactam compound
EP3583093B1 (en) Process for preparing substituted biphenyls
CN102531897B (en) Method for preparing alpha-replacing malonic acid diacetoxyiodo derivative
US8975203B2 (en) Diaryliodonium salt mixture and process for production thereof, and process for production of diaryliodonium compound
CN110498744B (en) Preparation method of 1-ethyl-3-nitrobenzene
EP2257530B1 (en) Process for preparing substituted biphenylanilides
CN105017066A (en) Chlorinated azide preparation method
EP3215489B1 (en) Method for the preparation of 1-(2-halogen-ethyl)-4 piperidine-carboxylic acid ethyl esters
CN112004796B (en) Process for producing N, N-disubstituted amide and catalyst for producing N, N-disubstituted amide
US10844005B1 (en) Method for preparing an N-cyclopropylmethyl aniline compound
CN104370835A (en) Preparation method of triazole derivative
RU2769996C1 (en) Method for obtaining hydroxyalkyl-containing azooxides
US11780791B2 (en) (6Z,9Z)-6,9-dodecadien-1-yne and a process for preparing the same
CN102382056B (en) Preparation method of 5-hydroxyl-substituted pyrazole
JP5609041B2 (en) Process for producing hydroxy (alkyl) piperazines
EP2865662A1 (en) Process for the preparation of a thrombopoietin agonist
CN105251497A (en) Solid catalyst, and preparation method and applications thereof
RU2541796C2 (en) Method of obtaining bis-(3-methoxybenzamidyl)-tetrathiazacycloalkanes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13812639

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13812639

Country of ref document: EP

Kind code of ref document: A1